bulk drug business continued to underperform due regulatory issues affecting supplies to the US. Photo: Pradeep Gaur/Mintinformed shareholders that... ...http://www.24dunia.com/english/mutualfund/showgroup/20322307.html
NEW DELHI: Ranbaxy Labs reported net loss of Rs 1,030 crore for the quarter ended December, hit by higher tax payment, a dip in sales in its... ...http://economictimes.indiatimes.com/markets/stocks/news/ranbaxy-q3-consolidated-loss-widens-to-rs-1030-crore/articleshow/46041783.cms
Ranbaxy's weak performance in the December quarter added to the disappointment of its shareholders who were hoping for some respite. Earlier on... ...http://www.thehindubusinessline.com/companies/ranbaxy-profits-hit-by-lower-us-sales/article6831065.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication
Israel-based Teva Pharma subsidiary, Ivax Pharmaceuticals, will now be able to sell the Nexium generic in 20-mg and 40-mg capsules following USFDA... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=86407&sid=2
Buy Nexium Online Canada --- Cheap...